The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease. - Wikidata - wikimedia - TriplyDB

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

http://www.wikidata.org/entity/Q34062230

about

CERAD practice effects and attrition bias in a dementia prevention trial Everyday cognition scales are related to cognitive function in the early stage of probable Alzheimer's disease and FDG-PET findings The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study Novel image-novel location object recognition task sensitive to age-related cognitive decline in nondemented elderly.Neural correlates associated with cognitive decline in late-life depression.Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study.Trajectory of Cognitive Decline After Incident Stroke.Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods.Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores Careful neuropsychological testing reveals a novel genetic marker, GSTO1*C, linked to the pre-stage of Alzheimer's disease.CERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's Disease Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.An in vivo evaluation of cerebral cortical amyloid with [18F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients.Use of Anti-Dementia Drugs in Relation to Change in Cognition, Behavior, and Functioning in Alzheimer's Disease over a Three-Year Period: Kuopio ALSOVA Study.Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.[(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies.The effectiveness of reality orientation in the treatment of Alzheimer's disease.A normative study of total scores of the CERAD neuropsychological assessment battery in an educationally diverse elderly population.Early detection of Alzheimer's disease with a total score of the German CERAD.

P2860

Q33574782-C01EBB5D-3F86-417D-A505-1E1E58E49597 Q33687460-778C4740-6CCD-41ED-8776-5BCDAC067647 Q34975011-1EEBFFF8-5E11-437D-92F4-63E26BA457DA Q35678134-D23EBD89-0E15-4EDF-852C-45BE13E55419 Q35914602-018B225A-6429-4E0D-8687-88C3D68AFBA8 Q36047779-CB61A789-D2EC-49DA-984C-4C885570D924 Q36304702-C8EC834C-F203-4BE3-901D-0642B09DCC32 Q36402089-29CE4EC4-7E8C-403D-8F82-2A1BD605F949 Q36863807-E9398E4B-A930-4057-A994-365DC8081AB9 Q37457413-15878032-90EE-4701-B7CC-1790AFABBF5F Q37573631-25628BE8-54AC-4F8B-B10E-74DCB610D9C5 Q37588171-0A3D3AE3-2E94-4EB3-94EA-30EF403DDCD2 Q37605374-787BFE20-6784-4ED3-B7E5-68FAFABED995 Q40457921-A5DC5CA1-EA3E-442A-9499-3261203C7A73 Q41205194-B699A0A4-418E-4602-B774-A05CEAA83986 Q46404384-163143C4-5A9C-43E3-870F-3556CA2E45CC Q48342095-9D7EC6B0-1540-4834-BB59-E63F36AD8DCB Q50601548-298EE9D8-B1FB-446D-B4BA-8687F5B344FA Q50630394-3F637543-513A-4C89-B6BF-BD697FEF3240 Q51847084-05C3846A-F5C7-40C5-AA65-798F882724F7

P2860

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

http://www.wikidata.org/entity/Q34062230

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

@ast

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

@en

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

@nl

type

label

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

@ast

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

@en

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

@nl

prefLabel

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

@ast

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

@en

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease.

@nl

P1433

Q34062230-4B9BE542-F630-4297-B1F7-C669C8D647F0

P1476

Q34062230-9DE193E7-B43B-416D-9790-85185BCFA65E

P2093

Q34062230-926FFD4D-47C3-4A51-AFA4-B1899206B6E6

Q34062230-BD9878AE-43B3-4073-906F-54D719C09023

Q34062230-D2A0240F-54A8-4293-9DB5-B0A1366C222F

P2860

Q34062230-00AF13A2-E299-4B9A-975B-3F35E8C0BEC8

Q34062230-07E7D966-3471-4CE0-8862-5EF31DD3725B

Q34062230-0B649F14-1C2A-4507-89C7-5245B25C8C15

Q34062230-0D6552AA-315C-4C51-8916-B043D5025EEF

Q34062230-1954F7D0-6D2C-4CE2-85C2-4D935E62ACFD

Q34062230-32AB4286-17A9-422C-AEFB-A41D7989333C

Q34062230-4CAE10C4-9557-4168-B4AC-682EC4517E20

Q34062230-8EEC46F6-F29D-4C97-9B56-A19FD6EA328D

Q34062230-9336EB1A-44A6-46A7-9A09-0B93A159872B

Q34062230-A4138364-3C06-4EE0-9A76-DA23B9CB3762

P304

Q34062230-C6736DC5-66BD-4654-93DB-D7F656D1F9D2

P31

Q34062230-F5509B29-FCB1-4A32-9873-C597C8027524

P356

Q34062230-EFDB8A83-58D6-48FF-A062-245B85855F15

P407

Q34062230-A2C3B6E7-DA97-4B0E-80C6-79CDF04D31C7

P433

Q34062230-D3D3F87F-B778-4E39-9D74-354B9E7BBC94

P478

Q34062230-3DF5CAAE-1EE1-4BCB-840B-D3CF8DA69B3D

P50

Q34062230-67501AC1-1126-4254-8686-803CEB5071B5

P577

Q34062230-7151E964-4F28-47F5-A55A-9DC09625A291

P5875

Q34062230-C1316AA7-FABE-4F66-A589-5970704A122B

P698

Q34062230-4C941897-301E-4E1D-8687-9910B91EBD4B

P921

Q34062230-24FCD990-8DFF-4124-A36E-58D88B2F459D

P932

Q34062230-DFBB9FF6-36D7-4801-BC58-4CAF13E96B7A

P356

WAD.0B013E3181B76415

P1433

Alzheimer Disease and Associated Disorders

P1476

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease

@en

P2093

C Munro Cullum

http://www.w3.org/2001/XMLSchema#string

Heidi C Rossetti

http://www.w3.org/2001/XMLSchema#string

Laura H Lacritz

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease.

Neuropsychological subgroups of patients with Alzheimer's disease: an examination of the first 10 years of CERAD data.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease.

Empirical techniques for determining the reliability, magnitude, and pattern of neuropsychological change after epilepsy surgery.

Rates of progression in mild cognitive impairment and early Alzheimer's disease.

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

A total score for the CERAD neuropsychological battery.

P304

138-142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/WAD.0B013E3181B76415

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44633126

http://www.w3.org/2001/XMLSchema#string

P698

20505431

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2920638

http://www.w3.org/2001/XMLSchema#string